Meeting
2020 ASCO Virtual Scientific Program
An international cohort study investigating the impact of age on clinical outcome in patients with hepatocellular carcinoma treated with sorafenib.
Authors
Rohini Sharma
Imperial College London, London, United Kingdom
Rohini Sharma , Saur Hajiev , Leila Motedayan Aval , Dominik Bettinger , Tadaaki Arizumi , Mario Pirisi , Lorenza Rimassa , Nicola Personeni , Tiziana Pressiani , Laura Giordano , Masatoshi Kudo , Robert Thimme , Joong-Won Park , Tamar Hamosh Taddei , David Edward Kaplan , Ramya Ramaswami , David James Pinato , Elias Allara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Geriatric Models of Care
Citation
J Clin Oncol 38: 2020 (suppl; abstr 12049)
DOI
10.1200/JCO.2020.38.15_suppl.12049
Abstract #
12049
Poster Bd #
337
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
Efficacy of sorafenib in patients with oligometastatic hepatoceulluar carcinoma (HCC).
First Author: Kiruthikah Thillai
Poster
2014 Gastrointestinal Cancers Symposium
Collective analysis of efficacy and safety of patients with advanced hepatocellular carcinoma (HCC) enrolled into early-phase clinical trials.
First Author: Vinu Madhusudanannair
Poster
2014 Gastrointestinal Cancers Symposium
A multicenter phase II study of sorafenib in Japanese patients with hepatocellular carcinoma and Child Pugh A or B cirrhosis.
First Author: Eiichiro Suzuki
Poster
2024 ASCO Genitourinary Cancers Symposium
Real-world efficacy and toxicity of ipilimumab and nivolumab as first line treatment of metastatic renal cell carcinoma (mRCC) in a subpopulation of elderly and poor performance status patients.
First Author: Ana-Alicia Beltran-Bless